S4E4: When the Peer Group Shrinks: Executive Compensation in Oil & Gas

S4E4: When the Peer Group Shrinks: Executive Compensation in Oil & Gas

Season 4 of Pearl Meyer Unscripted is looking at executive compensation through an industry lens. In our first episode examining the oil and gas industry, co-hosts Mark Rosen [https://pearlmeyer.com/our-people/mark-rosen] and Aalap Shah [https://pearlmeyer.com/our-people/aalap-shah] are joined by Malcom Adkins [https://pearlmeyer.com/our-people/malcolm-adkins] to discuss how compensation committees are navigating a smaller public-company universe, rethinking peer group design, and evaluating whether traditional approaches to performance measurement still fit today’s oil and gas market.

S4E3: The Life Sciences IPO Playbook: Key Compensation Decisions Before Going Public

Season 4 of Pearl Meyer Unscripted is looking at executive compensation through an industry lens. In this episode, co-hosts Mark Rosen [https://pearlmeyer.com/our-people/mark-rosen] and Aalap Shah [https://pearlmeyer.com/our-people/aalap-shah] are joined by Rob James [https://pearlmeyer.com/our-people/robert-james] to discuss the key compensation issues life sciences companies should address when preparing to go public.

S4E2: Burn Rate, Dilution, and the Fight for Life Sciences Talent

Season 4 of Pearl Meyer Unscripted is looking at executive compensation through an industry lens. In this episode, co-hosts Mark Rosen [https://pearlmeyer.com/our-people/mark-rosen] and Aalap Shah [https://pearlmeyer.com/our-people/aalap-shah] are joined by Matt Molberger [https://pearlmeyer.com/our-people/matt-molberger] to discuss the key equity strategy “levers” that life sciences companies can use to manage their share burn rates and preserve equity plan pools. Related Content: Looking Beyond Gross Burn Rate in Life Sciences Equity Programs [https://pearlmeyer.com/insights-and-research/article/looking-beyond-gross-burn-rate-in-life-sciences-equity-programs] Inducement Awards in Biopharma [https://pearlmeyer.com/insights-and-research/article/inducement-awards-in-biopharma]

S4E1: Pressure Testing Annual Incentive Programs for Emerging Growth Life Science Companies

Season 4 of Pearl Meyer Unscripted is looking at executive compensation through an industry lens. In the first episode, co-hosts Mark Rosen [https://pearlmeyer.com/our-people/mark-rosen] and Aalap Shah [https://pearlmeyer.com/our-people/aalap-shah] speak with Terry Newth [https://pearlmeyer.com/our-people/terry-newth], the founder of Pearl Meyer's Life Sciences Practice, about creating a balanced annual incentive program and process. Related Content: Incentive Plan Design in Early-Stage Growth Companies: Navigating Goal Adjustments During the Performance Period [https://pearlmeyer.com/insights-and-research/article/incentive-plan-design-in-early-stage-growth-companies] Setting Annual Incentive Compensation Goals in Biotech [https://pearlmeyer.com/insights-and-research/advisor-blog/setting-annual-incentive-compensation-goals-in-biotech]

S3E6: The PE CFO Balancing Act: Play Maker and Game Manager

Today’s private equity CFO must do far more than manage the numbers. In the final episode of Season 3 of Pearl Meyer Unscripted, David Clary and Vamsi Tetali explore why the traditional “game manager” CFO profile breaks down in high-constraint environments, and how strategic CFOs balance capital discipline, liquidity management, and exit readiness—without becoming the “chief no officer.” The conversation covers CEO partnership, FP&A, operational trade-offs, leadership assessment, and what PE sponsors should look for when hiring truly value-creating CFO talent.